OBZ
- Product code
- OBZ
- Device name
- Alpha-1-Antitrypsin Kit, Qualitative Phenotype
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5130
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 2 (all years; only the last 3 years are listed here)
FDA classification definition
The alpha-1-antitrypsin qualitative phenotype test result is used as an aid in the diagnosis of alpha-1-antitrypsin deficiency in conjunction with clinical and other laboratory findings. For in vitro diagnostic use only.
Official FDA classification page: OBZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).